Verofilcon A contact lenses
DeviceSpherical soft contact lenses for daily disposable wear
Other names: PRECISION1™
NCT Number: NCT04528017
The primary objective of this study is to evaluate the overall performance of PRECISION1 contact lenses when compared to Clariti 1-Day contact lenses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alcon Investigator 6565, Maitland, Florida, United States
Subjects are expected to attend 3 study visits and wear the PRECISION1 and Clariti 1-Day study lenses in a crossover design for approximately 8 days of exposure to each study lens type. The expected duration of subject participation is up to 22 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria
Key Exclusion Criteria:
Spherical soft contact lenses for daily disposable wear
Other names: PRECISION1™
Spherical soft contact lenses for daily disposable wear
Other names: CooperVision® clariti® 1 day, Clariti 1-Day
Time frame: Day 8 (-0/+3 days) after 10 (-2/+6) hours of wear, each study lens type
Distance VA was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07614113
Eye Diseases, Myopia
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06716372
Eye Diseases, Myopia
Taipei, Taiwan
View Trial DetailsNCT06716385
Eye Diseases, Myopia
Taipei, Taiwan
View Trial DetailsNCT06884202
Eye Diseases, Myopia
Los Angeles, California, United States
View Trial Details